Jul 11, 2016 | Coding, Billing, and Collections, Compliance, Legal, and Malpractice, Laboratory Instruments & Laboratory Equipment, Laboratory Management and Operations, Laboratory Pathology, Laboratory Testing
The National Institute of Health’s ClinVar public database of genetic variation is demonstrating good accuracy, and a handful of clinical labs are learning to share and review this relatively small genetic database
In the analysis of genomic variants, data sharing is proving to be an important tool for researchers, scientists, pathologists, and clinical laboratory scientists.
Accessible databases like ClinVar, which was launched by the National Institute of Health (NIH) in 2013, have emerged to aggregate genetic sequencing with acceptable results. ClinVar exists to meet the needs of the medical genetics community. It collaborates with organizations to make pertinent genetic information available.
ClinVar is an archive of compiled data relating to genotype and phenotype variations among humans. Through this database, individuals can present and peruse submissions regarding variants found in patient samples.
ClinVar is averaging about 6,000 submissions per month by both commercial laboratory companies and reference labs. Major contributors to the database include: (more…)
Jun 6, 2016 | Digital Pathology, Instruments & Equipment, Laboratory Instruments & Laboratory Equipment, Laboratory Management and Operations, Laboratory News, Laboratory Operations, Laboratory Pathology, Laboratory Testing
Utah-based Tute Genomics and UNIConnect will partner with Newborn Screening Ontario to uncover rare but treatable diseases in newborns
In the Canadian province of Ontario, next-generation gene sequencing will soon be part of newborn screening. This development is another confirmation for clinical laboratory managers and pathologists that genetic information from such diagnostic testing is contributing to improvements in clinical care.
Newborn Screening Ontario (NSO) is teaming up with Tute Genomics of Provo, Utah, and UNIConnect of Sandy, Utah, to enhance the province’s testing program for rare but treatable diseases in newborns.
The Ontario Ministry of Health and Long-Term Care is contracting with NSO to offer a next-generation sequencing testing panel and a multiple ligation-dependent probe amplification assay for the diagnostic confirmation of a variety of disorders. (more…)
May 2, 2016 | Instruments & Equipment, Laboratory News, Laboratory Operations, Laboratory Pathology, Management & Operations, News From Dark Daily
At Human Longevity, Inc. and the United Kingdom’s 100,000 Genome Project, knowledge gained from whole-genome sequencing is starting to be used to improve patient care
NEW ORLEANS, LA—Whole-human gene sequencing is poised to provide significant contributions to improving clinical care. That was one conclusion from expert speakers at the 21st annual Executive War College on Medical Laboratory and Pathology Management that happened here this week.
How fast knowledge from whole-human gene sequencing finds its way into clinical diagnostics and healthcare can be debated. But what is unquestioned, based on these presentations, is that insights gained from the analysis of large numbers of human genomes will trigger a revolution in how pathologists and physicians diagnose, treat, and care for patients. (more…)
Apr 26, 2016
PRESS RELEASE
THE DARK REPORT
21806 Briarcliff Dr.
Spicewood, Texas 78669
512-264-7103 o
512-264-0969 f
FOR IMMEDIATE RELEASE
Media Contact: Ron Martin
rbmartin@darkreport.com
New Orleans, LA (April 26, 2016) — A top-flight roster of lab experts and innovators gather in New Orleans April 26-27, 2016, for the annual Executive War College on Lab and Pathology Management. This event—the nation’s largest, most respected gathering on lab management and operations—is taking place at the Sheraton Hotel on Canal Street. Now in its 21st year, Executive War College this year expects record-breaking attendance by senior lab executives, administrators, and pathologists from all over the world.
“Never before has the clinical laboratory industry and anatomic pathology profession experienced such a fast-paced transformation of the American healthcare system as is happening now,” says Robert L. Michel, producer of Executive War College and Editor-In-Chief of The Dark Report. “As one example, the profession of lab medicine has the unprecedented opportunity to take the leading role in advancing the practice of precision medicine, informed by knowledge derived from genetic testing and whole-human genome sequencing.
Specifically addressing these precision medicine opportunities are General Sessions Tuesday, April 27, and Wednesday, April 28, noted Michel. These are world-class sessions, from esteemed speakers with international academic and clinical research reputations.”
The Executive War College 2016 General Session presentations will include:
- “Genome Sequencing and Genetic Medicine: How It’s Changing Healthcare Today and What Providers Can Expect Moving Forward,” Wednesday, April 27 at 9:40 am, featuring Brad Perkins, M.D., Chief Medical Officer with Human Longevity in San Diego, CA
- “Genomics, Data & Personalized Medicine – The UK Experience of Transforming Care for the Future,” Wednesday, April 27 at 10:40 am, featuring Professor Sue Hill, OBE, Ph.D., Dsc, CBiol, FlBiol, Hon FRCP, Chief Scientific Officer with the NHS England
- A panel discussion Tuesday afternoon, April 26 at 4:30 pm, entitled “Understanding the New Ways that Payers and Labs are Interacting as Healthcare Transforms, Different Payment Models Emerge, and Genetic Testing Creates New Opportunities to Improve Patient Outcomes,” bringing together experts with a range of perspectives on these issues.
In addition to the above one-of-a-kind forums, Executive War College 2016 offers more than 50 more information-packed presentations comprising an enlightening and expansive range of topics, plus special sessions for pathology professionals, and interactive roundtables for lab CFOs, CIOs, Sales Managers, and Marketing Officers. For more information on Executive War College 2016, visit http://www.executivewarcollege.com. You may also contact Chris Garcia at 210-912-7716.
About THE DARK REPORT
Established in 1995, THE DARK REPORT is the leading source of exclusive business intelligence for laboratory CEOs, COOs, CFOs, Pathologists and Senior industry executives. It is widely read by leaders in laboratory medicine and diagnostics. The Dark Report produces the famous Executive War College on Laboratory and Pathology Management every spring, which showcases innovations by the nation’s and globe’s leading laboratory organizations. Dark Daily is an Internet-based e-briefing intelligence service, read worldwide by thought leaders in laboratory and pathology management. Other well-known conferences conducted by THE DARK REPORT are Lab Quality Confab (on the use of Lean and Six Sigma methods in labs and hospitals) and Molecular Summit (on the integration of in vivo and in vitro diagnostics). THE DARK REPORT co-produces Frontiers in Laboratory Medicine annually in the United Kingdom; Executive Edge bi-annually in Canada; and The Business of Pathology bi-annually in Australia.
-end-
Apr 22, 2016 | Compliance, Legal, and Malpractice, Digital Pathology, Instruments & Equipment, Laboratory Management and Operations, Laboratory News, Laboratory Operations, Laboratory Pathology, Laboratory Testing
A hospital in Virginia now offers a genetic service to new parents that could impact clinical pathology laboratories if it develops into a trend
Here’s a first in the rapidly-developing field of pharmacogenomics testing. A hospital in Virginia announced that it would offer a free pharmacogenomics test to newborns. This is a development that will catch the attention of clinical pathologists and medical laboratory professionals at other hospitals across the country.
Inova Women’s Services at the Inova Woman’s Hospital on the Inova Fairfax Medical Campus in Falls Church, VA, has begun offering free MediMap tests to newborns. MediMap is a pharmacogenomics (PGx) test that looks for variations in seven genes that could indicate a child might process certain drugs differently than the majority of the population.
The program is an example of a well-known and often-used marketing tactic: “Buy X and get Y free!” Given the choice between a new free diaper bag and a free, painless test that, as Inova’s website states, “personalizes prescriptions to more effectively treat and manage illnesses in the future,” what new mother would choose the diaper bag? (more…)
